Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Likely Trend of INBS Stock Following the News Following the announcement, shares of the company tumbled 5.1% and closed at $1.67 yesterday. In the past six months, INBS’ shares have lost 8.2% ...

This expected patent will enhance INBS’ existing intellectual property ... public offering of 1,500,000 shares of common stock at a public offering price of $2.00 per share of common stock ...

Intelligent Bio Solutions Partners With CenEx ...

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential r ...

ultimately boosting the performance of the INBS stock over time. Meanwhile, INBS currently has a market capitalization of $11.9 billion. The company expects an earnings growth of 80.4% in 2025.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...